Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc. completed its business combination with Amplitude Healthcare Acquisition Corporation, the blank check company that traded on Nasdaq under the ticker AMHC and completed its IPO in 2021. Amplitude Healthcare Acquisition Corporation was sponsored by Amplitude Healthcare, and the SPAC was formed to target opportunities in the healthcare and life sciences sector. Jasper Therapeutics is a clinical-stage biopharmaceutical company focused on hematopoietic stem cell transplantation therapies. The December 20, 2023 Form 8-K, filed under accession number 0001213900-23-097100, represents a post-combination disclosure by the combined public entity. For complete filing history, sponsor details, and deal metrics on AMHC and thousands of other SPACs, sign up for full data access at SpacDesk.